non-small cell lung cancer
Genotype-driven therapies for non-small cell lung cancer: focus on EGFR, KRAS and ALK gene abnormalities.
Genotype-driven therapies for <span class="disease" id="21904575-0-30-56">non-small cell lung cancer</span>: focus on EGFR, KRAS and <span class="gene" id="21904575-0-82-85">ALK</span> gene abnormalities.